# Dexcel Pharma Ltd. – FDA Inspection, Feb 16, 2017

Source: https://www.keypedia.com/records/fda_inspections/dexcel-pharma-ltd/cfef2ab3-f0eb-4b7b-bb92-e3ec84498568
Source feed: FDA_Inspections

> FDA inspection 1007877 of Dexcel Pharma Ltd., February 16, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1007877
- Company Name: Dexcel Pharma Ltd.
- Inspection Date: 2017-02-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1195631 - 2022-12-14
- [FDA Inspection 1097285 - 2019-07-24](https://www.keypedia.com/records/fda_inspections/dexcel-pharma-ltd/22fbe152-1d95-4a72-a2b9-b19e079e4ac5)
- FDA Inspection 836838 - 2013-06-05

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/pratik-s-upadhyay/22ff2e0b-17d4-4c91-a3f0-c7e30b7a115b)
- [FDA Associated Person](https://www.keypedia.com/people/zhongren-wu/416f09a6-f225-4d23-a305-34f96a5c78f0)

Company: https://www.keypedia.com/companies/dexcel-pharma-ltd/4ec8aec2-8e4a-4886-8b52-f6d83c19e0c8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c